Skip to main content

Table 2 Identified medical problems by feeding type from thirteen participating pediatric Emergency Services in Majorca, Spain, between August and December 2020

From: Does breastfeeding protect children from COVID-19? An observational study from pediatric services in Majorca, Spain

Clinical or laboratory features

No breastfeeding

Any breastfeeding

P value

OR (95%CI)

Number (%)

220 (32%)

471 (68%)

  

Presenting Symptoms

 Fever

86 (39.1%)

184 (39.1%)

0.995

1.00 (0.72, 1.38)

 Asthenia

20 (9.1%)

48 (10.2%)

0.651

0.88 (0.50, 1.52)

 Dyspnea

9 (4.1%)

33 (7.0%)

0.069

0.50 (0.23, 1.05)

 Coughing

64 (29.1%)

133 (28.2%)

0.817

1.04 (0.73, 1.48)

 Sore throat

30 (13.6%)

70 (14.9%)

0.669

0.90 (0.57, 1.43)

 Ear ache

14 (6.4%)

19 (4.0%)

0.184

1.61 (0.79, 3.28)

 Abdominal pain

28 (12.7%)

48 (10.2%)

0.321

1.28 (0.78, 2.11)

 Diarrhoea

25 (11.4%)

40 (8.5%)

0.230

1.38 (0.81, 2.34)

Diagnosis

 Acute pharyngitis

9 (4.1%)

20 (4.2%)

0.924

0.96 (0.43, 2.14)

 Acute otitis media

20 (9.1%)

22 (4.7%)

0.026*

2.04 (1.08, 3.82)

 Laryngitis

3 (1.4%)

7 (1.5%)

0.900

0.91 (0.23, 3.57)

 Asthma

8 (3.6%)

27 (5.7%)

0.245

0.62 (0.27, 1.38)

 Acute gastroenteritis

20 (9.1%)

31 (6.6%)

0.241

1.41 (0.78, 2.55)

 Acute appendicitis

0 (0%)

2 (0.4%)

  

 Seizures

1 (0.5%)

4 (0.8%)

0.332

0.23 (0.01, 4.39)

 Headache

8 (3.6%)

4 (0.8%)

0.016*

4.40 (1.31, 14.79)

 Febrile syndrome

22 (10%)

37 (7.9%)

0.348

1.30 (0.74, 2.26)

 Fracture

1 (0.5%)

7 (1.5%)

0.265

0.302 (0.03, 2.47)

 Dermatitis

4 (1.8%)

13 (2.8%)

0.459

0.65 (0.21, 2.02)

 Rash

2 (0.9%)

6 (1.3%)

0.677

0.71 (0.14, 3.55)

 Symptomatic patients

203 (92.3%)

431 (91.5%)

0.73

0.90 (049, 1.63)

Positive results of SARS-CoV-2 RT-PCR tests

 From symptomatic and asymptomatic patients

8 (3.6%)

8 (1.6%)

0.056

2.18 (1.19, 3.17)

 From symptomatic patients

8 (3.9%)

7 (1.6%)

0.036*

2.48 (1.45, 3.51)

  1. Abbreviations: * ≤ 0.05; CI Confidence interval, OR Odds ratio, RT-PCR Real-time polymerase chain reaction, SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2